PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
+6.2%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$2.34B
AUM Growth
+$16.6M
(+0.71%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
72.44%
Holding
37
New
–
Increased
22
Reduced
2
Closed
1
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$29.2M |
| 2 |
Insmed
INSM
|
+$17M |
| 3 |
SHPG
Shire pic
SHPG
|
+$8.28M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
+$6.69M |
| 5 |
CELG
Celgene Corp
CELG
|
+$6.35M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$69.5M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$14.3M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
+$3.07M |
Sector Composition
| 1 | Healthcare | 92.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exact Sciences
EXAS
$10.2B
| $12.6M | 0.54% |
312,719
+1,843
| +0.6% | +$74.3K |
|
|
DRNA
27
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.79M | 0.2% |
500,913
| – | – |
|
|
VIRX
28
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.16M | 0.14% |
33,214
| – | – |
|
|
ALIM
29
DELISTED
Alimera Sciences, Inc.
ALIM
| $3.1M | 0.13% |
200,920
| – | – |
|
|
ZGNX
30
DELISTED
Zogenix, Inc.
ZGNX
| $1.18M | 0.05% |
29,500
| – | – |
|
|
ACGN
31
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $1.13M | 0.05% |
4,537
| – | – |
|
32
Cytokinetics
CYTK
$6.12B
| $891K | 0.04% |
123,686
| – | – |
|
33
Ocugen
OCGN
$334M
| $833K | 0.04% |
5,049
| – | – |
|
|
TRVN
34
DELISTED
Trevena, Inc.
TRVN
| $560K | 0.02% |
546
| – | – |
|
|
SPHS
35
DELISTED
Sophiris Bio, Inc.
SPHS
| $496K | 0.02% |
247,000
| – | – |
|
|
MLNT
36
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $375K | 0.02% |
10,138
| – | – |
|
|
BIVV
37
DELISTED
Bioverativ Inc. Common Stock
BIVV
| – | – |
-264,400
| Closed | -$14.3M |
|